{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:55:05Z","timestamp":1792799705843,"version":"4.5.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515010443"],"award-info":[{"award-number":["2023A1515010443"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Municipal Science and Technology Bureau-Key R&D Program","award":["2023B03J1387"],"award-info":[{"award-number":["2023B03J1387"]}],"id":[{"id":"https:\/\/ror.org\/0560dtp08","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013262","name":"State Key Laboratory of Respiratory Diseases","doi-asserted-by":"crossref","award":["SKLRD-Z-202313"],"award-info":[{"award-number":["SKLRD-Z-202313"]}],"id":[{"id":"10.13039\/100013262","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Academic Affairs Office of Guangzhou Medical University - 2022 Academic Innovation Ability Improvement Project","award":["01-408-2201096"],"award-info":[{"award-number":["01-408-2201096"]}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Lipid metabolism disorder is increasingly recognized as hallmarks of pulmonary hypertension (PH). Fatty acid-binding proteins (FABPs), particularly FABP4 and FABP5, which regulate lipid transport and metabolism of fatty acid, are thought to contribute to the development of PH. However, it remains unclear whether FABP4 and FABP5 serve as therapeutic targets for the treatment of PH. Measurements and Main.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The levels of FABP4\/5 were elevated in the plasma and lung tissues of idiopathic pulmonary arterial hypertension (IPAH) patients, as well as in the lung tissues of the PH rat model compared with control. The circulating levels of FABP4 of IPAH patients were correlated with mean pulmonary arterial pressure (mPAP). To determine the preventive or therapeutic effect of FABP4 and FABP5 inhibition, FABP4 and FABP5 inhibitors alone or combination were administered at early (days 2 following monocrotaline [MCT] injection) and late (day 12 following MCT injection) stage of PH rat model, respectively. Combined treatment with FABP4\/5 inhibitors in the early stage of the MCT-PH rat model effectively reduced right ventricular systolic pressure (RVSP) and improved right ventricular (RV) function, accompanied by reductions in pulmonary vascular and RV fibrosis, as well as blood lipid levels, lipid peroxidation, and inflammation. Combined treatment with FABP4\/5 inhibitors at the late stage of MCT-PH improved RV function, suppressed pulmonary vascular and RV fibrosis, and lowered blood lipid levels, but did not affect RVSP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combined inhibition of FABP4 and FABP5 can prevent the pathogenesis of PH, representing a potential therapeutic strategy for PH. p<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1165\/rcmb.2024-0352oc","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T20:01:03Z","timestamp":1760472063000},"page":"466-479","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":5,"title":["Combined inhibition of FABP4\/5 ameliorates pulmonary hypertension by reducing pulmonary vascular and right ventricular fibrosis"],"prefix":"10.1093","volume":"74","author":[{"given":"Juan","family":"Li","sequence":"first","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Qiu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Lin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahao","family":"He","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Ren","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianuo","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanli","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanjie","family":"Mo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakai","family":"Xiao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Clinical Laboratory, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8682-6775","authenticated-orcid":false,"given":"Chunli","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, the First Affliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"2026082310065110800_aanaf012-B1","doi-asserted-by":"publisher","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"2026082310065110800_aanaf012-B2","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1164\/rccm.202009-3698OC","article-title":"Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension","volume":"204","author":"Boucly","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2026082310065110800_aanaf012-B3","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1177\/0300060519840130","article-title":"Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan","volume":"47","author":"Tynan","year":"2019","journal-title":"J Int Med Res"},{"key":"2026082310065110800_aanaf012-B4","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.5114\/aoms.2018.79242","article-title":"Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension","volume":"15","author":"Jonas","year":"2019","journal-title":"Arch Med Sci"},{"key":"2026082310065110800_aanaf012-B5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12933-023-01885-6","article-title":"Impact of diabetes mellitus on disease severity and patient survival in idiopathic pulmonary arterial hypertension: data from the polish multicentre registry (BNP-PL)","volume":"22","author":"Jonas","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026082310065110800_aanaf012-B6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.amjcard.2012.03.042","article-title":"Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension","volume":"110","author":"Zhao","year":"2012","journal-title":"Am J Cardiol"},{"key":"2026082310065110800_aanaf012-B7","doi-asserted-by":"publisher","first-page":"14280","DOI":"10.3390\/ijms241814280","article-title":"The impact of abnormal lipid metabolism on the occurrence risk of idiopathic pulmonary arterial hypertension","volume":"24","author":"Wei","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026082310065110800_aanaf012-B8","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.cell.2020.07.027","article-title":"SnapShot: FABP functions","volume":"182","author":"Li","year":"2020","journal-title":"Cell"},{"key":"2026082310065110800_aanaf012-B9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/nrendo.2015.122","article-title":"Metabolic functions of FABPs\u2014mechanisms and therapeutic implications","volume":"11","author":"Hotamisligil","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"2026082310065110800_aanaf012-B10","doi-asserted-by":"publisher","first-page":"575557","DOI":"10.3389\/fendo.2020.575557","article-title":"Independent and distinct associations of FABP4 and FABP5 with metabolic parameters in type 2 diabetes mellitus","volume":"11","author":"Furuhashi","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026082310065110800_aanaf012-B11","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.2337\/diabetes.48.10.1987","article-title":"Altered insulin secretion associated with reduced lipolytic efficiency in aP2-\/- mice","volume":"48","author":"Scheja","year":"1999","journal-title":"Diabetes"},{"key":"2026082310065110800_aanaf012-B12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2337\/diabetes.52.2.300","article-title":"Role of the fatty acid binding protein mal1 in obesity and insulin resistance","volume":"52","author":"Maeda","year":"2003","journal-title":"Diabetes"},{"key":"2026082310065110800_aanaf012-B13","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1165\/rcmb.2010-0376OC","article-title":"Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia","volume":"45","author":"Ghelfi","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026082310065110800_aanaf012-B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-nutr-062220-112240","article-title":"The multifunctional family of mammalian fatty acid-binding proteins","volume":"43","author":"Storch","year":"2023","journal-title":"Annu Rev Nutr"},{"key":"2026082310065110800_aanaf012-B15","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.3390\/ijms22031435","article-title":"Adipokines and metabolic regulators in human and experimental pulmonary arterial hypertension","volume":"22","author":"Papathanasiou","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026082310065110800_aanaf012-B16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.immuni.2022.06.001","article-title":"Very-low-density lipoprotein receptor-enhanced lipid metabolism in pancreatic stellate cells promotes pancreatic fibrosis","volume":"55","author":"Yang","year":"2022","journal-title":"Immunity"},{"key":"2026082310065110800_aanaf012-B17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbi.2023.02.012","article-title":"ACSL4 promotes microglia-mediated neuroinflammation by regulating lipid metabolism and VGLL4 expression","volume":"109","author":"Zhou","year":"2023","journal-title":"Brain Behav Immun"},{"key":"2026082310065110800_aanaf012-B18","doi-asserted-by":"publisher","first-page":"110670","DOI":"10.1016\/j.intimp.2023.110670","article-title":"Hyocholic acid retards renal fibrosis by regulating lipid metabolism and inflammatory response in a sheep model","volume":"122","author":"Zhang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"2026082310065110800_aanaf012-B19","doi-asserted-by":"publisher","first-page":"1802441","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur Respir J"},{"key":"2026082310065110800_aanaf012-B20","doi-asserted-by":"publisher","first-page":"566535","DOI":"10.3389\/fimmu.2020.566535","article-title":"Inhibition of fatty Acid-Binding protein 4 attenuated kidney fibrosis by mediating macrophage-to-myofibroblast transition","volume":"11","author":"Feng","year":"2020","journal-title":"Front Immunol"},{"key":"2026082310065110800_aanaf012-B21","doi-asserted-by":"publisher","first-page":"e2003721","DOI":"10.1002\/advs.202003721","article-title":"Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells","volume":"8","author":"Wu","year":"2021","journal-title":"Adv Sci (Weinh)"},{"key":"2026082310065110800_aanaf012-B22","doi-asserted-by":"publisher","first-page":"L135","DOI":"10.1152\/ajplung.00084.2019","article-title":"TRPV4 channel mediates adventitial fibroblast activation and adventitial remodeling in pulmonary hypertension","volume":"318","author":"Cussac","year":"2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026082310065110800_aanaf012-B23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1745-7270.2006.00123.x","article-title":"Transforming growth factor-beta1 induces transdifferentiation of fibroblasts into myofibroblasts in hypoxic pulmonary vascular remodeling","volume":"38","author":"Jiang","year":"2006","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"2026082310065110800_aanaf012-B24","doi-asserted-by":"publisher","first-page":"108389","DOI":"10.1016\/j.pharmthera.2023.108389","article-title":"Molecular mechanisms and targets of right ventricular fibrosis in pulmonary hypertension","volume":"244","author":"Bekedam","year":"2023","journal-title":"Pharmacol Ther"},{"key":"2026082310065110800_aanaf012-B25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1152\/japplphysiol.00148.2020","article-title":"Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension","volume":"129","author":"Akazawa","year":"2020","journal-title":"J Appl Physiol (1985)"},{"key":"2026082310065110800_aanaf012-B26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jare.2021.11.011","article-title":"Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt\/\u03b2-catenin pathway","volume":"40","author":"Lei","year":"2022","journal-title":"J Adv Res"},{"key":"2026082310065110800_aanaf012-B27","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.ejmech.2017.07.022","article-title":"Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review","volume":"138","author":"Floresta","year":"2017","journal-title":"Eur J Med Chem"},{"key":"2026082310065110800_aanaf012-B28","doi-asserted-by":"publisher","first-page":"3454","DOI":"10.1021\/acs.biochem.7b00194","article-title":"The antinociceptive agent SBFI-26 binds to anandamide transporters FABP5 and FABP7 at two different sites","volume":"56","author":"Hsu","year":"2017","journal-title":"Biochemistry"},{"key":"2026082310065110800_aanaf012-B29","doi-asserted-by":"publisher","first-page":"e50968","DOI":"10.1371\/journal.pone.0050968","article-title":"Targeting fatty acid binding protein (FABP) anandamide transporters\u2014a novel strategy for development of anti-inflammatory and anti-nociceptive drugs","volume":"7","author":"Berger","year":"2012","journal-title":"PLoS One"},{"key":"2026082310065110800_aanaf012-B30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41413-022-00211-2","article-title":"FABP4 secreted by M1-polarized macrophages promotes synovitis and angiogenesis to exacerbate rheumatoid arthritis","volume":"10","author":"Guo","year":"2022","journal-title":"Bone Res"},{"key":"2026082310065110800_aanaf012-B31","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1111\/bph.15000","article-title":"Tetramethylpyrazine: a promising drug for the treatment of pulmonary hypertension","volume":"177","author":"Chen","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2026082310065110800_aanaf012-B32","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1161\/CIRCULATIONAHA.120.048845","article-title":"ALDH1A3 coordinates metabolism with gene regulation in pulmonary arterial hypertension","volume":"143","author":"Li","year":"2021","journal-title":"Circulation"},{"key":"2026082310065110800_aanaf012-B33","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/jcp.30622","article-title":"Inhibition of FABP4 attenuates hyperoxia-induced lung injury and fibrosis via inhibiting TGF-\u03b2 signaling in neonatal rats","volume":"237","author":"Huang","year":"2022","journal-title":"J Cell Physiol"},{"key":"2026082310065110800_aanaf012-B34","doi-asserted-by":"publisher","first-page":"D22","DOI":"10.1016\/j.jacc.2013.10.027","article-title":"Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology","volume":"62","author":"Vonk-Noordegraaf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026082310065110800_aanaf012-B35","doi-asserted-by":"publisher","first-page":"eadd8945","DOI":"10.1126\/sciimmunol.add8945","article-title":"Identification of a broadly fibrogenic macrophage subset induced by type 3 inflammation","volume":"8","author":"Fabre","year":"2023","journal-title":"Sci Immunol"},{"key":"2026082310065110800_aanaf012-B36","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1161\/01.cir.0000012754.72951.3d","article-title":"Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor","volume":"105","author":"Atkinson","year":"2002","journal-title":"Circulation"},{"key":"2026082310065110800_aanaf012-B37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension","volume":"26","author":"Lane","year":"2000","journal-title":"Nat Genet"},{"key":"2026082310065110800_aanaf012-B38","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1161\/CIRCULATIONAHA.108.821504","article-title":"Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease","volume":"119","author":"Long","year":"2009","journal-title":"Circulation"},{"key":"2026082310065110800_aanaf012-B39","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.123.066430","article-title":"BRCC3 regulation of ALK2 in vascular smooth muscle cells: implication in pulmonary hypertension","volume":"150","author":"Shen","year":"2024","journal-title":"Circulation"},{"key":"2026082310065110800_aanaf012-B40","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1126\/science.274.5291.1377","article-title":"Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein","volume":"274","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"2026082310065110800_aanaf012-B41","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/89076","article-title":"Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis","volume":"7","author":"Makowski","year":"2001","journal-title":"Nat Med"},{"key":"2026082310065110800_aanaf012-B42","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1161\/01.CIR.0000141735.13202.B6","article-title":"Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice","volume":"110","author":"Boord","year":"2004","journal-title":"Circulation"},{"key":"2026082310065110800_aanaf012-B43","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/s41586-021-04137-3","article-title":"A hormone complex of FABP4 and nucleoside kinases regulates islet function","volume":"600","author":"Prentice","year":"2021","journal-title":"Nature"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/advance-article-pdf\/doi\/10.1165\/rcmb.2024-0352OC\/66544705\/rcmb.2024-0352oc.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/74\/4\/466\/68222067\/rcmb.2024-0352oc.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/74\/4\/466\/68222067\/rcmb.2024-0352oc.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:07:07Z","timestamp":1787494027000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/74\/4\/466\/8438656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,10,14]]},"published-print":{"date-parts":[[2026,4,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2024-0352oc","relation":{},"ISSN":["1535-4989"],"issn-type":[{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"2024-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}